Canada · Delayed Price · Currency is CAD Vantex Resources Statistics
Total Valuation
TSXV:VAX has a market cap or net worth of CAD 817,573. The enterprise value is 565,212.
| Market Cap | 817,573 |
| Enterprise Value | 565,212 |
Important Dates
The last earnings date was Tuesday, February 24, 2026.
| Earnings Date | Feb 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TSXV:VAX has 4.81 million shares outstanding.
| Current Share Class | 4.81M |
| Shares Outstanding | 4.81M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 5.73 |
| P/TBV Ratio | 5.73 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.62 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.08, with a Debt / Equity ratio of 0.09.
| Current Ratio | 2.08 |
| Quick Ratio | 2.01 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -46.75 |
Financial Efficiency
Return on equity (ROE) is -86.12% and return on invested capital (ROIC) is -35.02%.
| Return on Equity (ROE) | -86.12% |
| Return on Assets (ROA) | -25.46% |
| Return on Invested Capital (ROIC) | -35.02% |
| Return on Capital Employed (ROCE) | -119.15% |
| Weighted Average Cost of Capital (WACC) | 3.21% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +320.00% in the last 52 weeks. The beta is -0.24, so TSXV:VAX's price volatility has been lower than the market average.
| Beta (5Y) | -0.24 |
| 52-Week Price Change | +320.00% |
| 50-Day Moving Average | 0.10 |
| 200-Day Moving Average | 0.11 |
| Relative Strength Index (RSI) | 55.22 |
| Average Volume (20 Days) | 21,861 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -170,137 |
| Pretax Income | -215,957 |
| Net Income | -215,957 |
| EBITDA | -157,637 |
| EBIT | -170,137 |
| Earnings Per Share (EPS) | -0.04 |
Balance Sheet
The company has 264,552 in cash and 12,191 in debt, with a net cash position of 252,361 or 0.05 per share.
| Cash & Cash Equivalents | 264,552 |
| Total Debt | 12,191 |
| Net Cash | 252,361 |
| Net Cash Per Share | 0.05 |
| Equity (Book Value) | 142,798 |
| Book Value Per Share | 0.03 |
| Working Capital | 142,798 |
Cash Flow
| Operating Cash Flow | -150,320 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSXV:VAX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -26.41% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 18, 2018. It was a reverse split with a ratio of 0.2.
| Last Split Date | May 18, 2018 |
| Split Type | Reverse |
| Split Ratio | 0.2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |